logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Gustave Roussy

+33142114211
support-mon@gustaveroussy.fr
Source: Site record.
https://www.gustaveroussy.fr

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

The hope of curing cancer has a name: Gustave Roussy.Europe’s leading cancer center and the fourth-best cancer hospital in the world, according to Newsweek magazine, Gustave Roussy is a healthcare, research, and teaching institute that treats patients with all types of cancer, at every stage of life. Its expertise in rare cancers and complex tumors is internationally recognized.It brings together medical, scientific, and technological excellence in the service of patient care. Its internationally renowned experts are dedicated to fulfilling the Institute’s three missions: patient care, research, and teaching.

Business Status

Source: Human-provided. OPEN

Business Category

Source: Human-provided. Cancer treatment center

Business Subcategory

Source: Human-provided. Cancer treatment center
Source: Human-provided. Hospital
Source: Human-provided. Research institute
Source: Trial-derived.
595Total Trials
Source: Trial-derived.
130Recruiting Trials
Source: Trial-derived.
157Active Trials
Source: Trial-derived.
2Completed Trials
Source: Trial-derived.
661Unique Conditions
Source: Trial-derived.
363Unique Sponsors

Conditions

Source: Trial-derived. Breast Cancer (24)Source: Trial-derived. Ovarian Cancer (18)Source: Trial-derived. Advanced Solid Tumors (15)Source: Trial-derived. Prostate Cancer (15)Source: Trial-derived. Colorectal Cancer (14)Source: Trial-derived. Melanoma (14)Source: Trial-derived. Solid Tumor (13)Source: Trial-derived. Carcinoma, Non-Small-Cell Lung (12)

Sponsors

Source: Trial-derived. Hoffmann-La Roche (41)Source: Trial-derived. Merck Sharp & Dohme LLC (40)Source: Trial-derived. Amgen (31)Source: Trial-derived. Gustave Roussy, Cancer Campus, Grand Paris (30)Source: Trial-derived. UNICANCER (30)Source: Trial-derived. Pfizer (29)Source: Trial-derived. Centre Leon Berard (26)Source: Trial-derived. Eli Lilly and Company (26)

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Electronic data capture

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. SPECT / nuclear medicine
Source: AI-inferred. 12-lead ECG
Source: AI-inferred. Echocardiography

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Histology / pathology
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing
Source: AI-inferred. Pharmacokinetic bioanalysis
Source: AI-inferred. Sequencing / genomics
Source: AI-inferred. Specimen packaging and shipment
Source: AI-inferred. Biobanking

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Radiation therapy
Source: AI-inferred. Radiopharmaceutical handling and administration
Source: AI-inferred. Surgery / operating room

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Amenities

Amenities Available

Source: Google. Restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Left ventricular ejection fraction assessment
Source: AI-inferred. Electronic patient-reported outcome (ePRO) diary system
Source: AI-inferred. Measurable residual disease (MRD) assessment
Source: AI-inferred. Radiographic tumour imaging
Source: AI-inferred. Tumour BRAF V600 mutation testing
Source: AI-inferred. Tumour EGFR mutation testing
Source: AI-inferred. Tumour molecular mutation testing
Source: AI-inferred. Tumour response imaging